Accueil › Cancer du poumon non à petites cellules › Illinois › Waukegan
Essais cliniques pour Cancer du poumon non à petites cellules à Waukegan, IL
16 études pour Cancer du poumon non à petites cellules recherchent des participants dans et autour de Waukegan (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Recrutement en coursPhase 3
- AMG Libertyville - Oncology, Libertyville · à 8 mi
- Condell Memorial Hospital, Libertyville · à 8 mi
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Recrutement en coursPhase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · à 7 mi
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · à 10 mi
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Recrutement en coursPhase 2
- City of Hope Chicago, Zion · à 6 mi
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Recrutement en coursPhase 3
- Advocate Medical Group - Libertyville Oncology, Libertyville · à 8 mi
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Captain James A. Lovell Federal Health Care Center, North Chicago · à 3 mi
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- City of Hope® Cancer Center Chicago, Zion · à 6 mi
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Recrutement en coursPhase 3
- Research Site, Zion · à 6 mi
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- Research Site, North Chicago · à 3 mi
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Recrutement en coursPhase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · à 7 mi
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · à 10 mi
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Recrutement en coursPhase 3
- Cancer Treatment Centers of America (CTCA), Zion · à 6 mi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · à 7 mi
- AMG Libertyville - Oncology, Libertyville · à 8 mi
- Condell Memorial Hospital, Libertyville · à 8 mi
- et 1 autres
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · à 7 mi
- AMG Libertyville - Oncology, Libertyville · à 8 mi
- Condell Memorial Hospital, Libertyville · à 8 mi
- et 1 autres
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2/3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · à 7 mi
- AMG Libertyville - Oncology, Libertyville · à 8 mi
- Condell Memorial Hospital, Libertyville · à 8 mi
- et 1 autres
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · à 7 mi
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · à 10 mi
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Recrutement en coursPhase 2
- City of Hope at Chicago, Zion · à 6 mi
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Recrutement en coursÉtude observationnelle
- AMG Libertyville - Oncology, Libertyville · à 8 mi
- Condell Memorial Hospital, Libertyville · à 8 mi
Essais pour Cancer du poumon non à petites cellules dans d'autres villes
- Houston, TX145 études
- New York City, NY121 études
- Arlington, VA104 études
- Nashville, TN97 études
- Boston, MA90 études
- Los Angeles, CA87 études
- St. Louis, MO73 études
- Chicago, IL61 études
- Baltimore, MD60 études
- San Antonio, TX59 études
- Columbus, OH57 études
- Washington, DC55 études
Autres études à Waukegan
- Cancer du poumon16 études
- Cancer du sein12 études
- Colite ulcéreuse7 études
- Cancer du rein (carcinome à cellules rénales)7 études
- Cancer de l'ovaire6 études
- Cancer métastatique6 études
- Carcinome épidermoïde de la tête et du cou6 études
- Cancer colorectal6 études
- Cancer de la prostate6 études
- Mélanome5 études
- Leucémie aiguë myéloïde5 études
- Maladie de Crohn5 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.